For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo r ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

The research, published in the European Heart Journal, revealed that cold weather may increase the susceptibility to ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for ...

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...

A history of HDP is linked to increased risks of myocardial infarction, whether that’s with obstructive coronary arteries or ...

Women aged less than 50 years hospitalized with MI have gender-specific cardiovascular risk factors and experience typical chest pain.

The study found similar patterns in men and women, although there were some differences, especially for myocardial infarction ...